A detailed history of Morgan Stanley transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Morgan Stanley holds 611,731 shares of COLL stock, worth $18.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
611,731
Previous 631,082 3.07%
Holding current value
$18.8 Million
Previous $20.3 Million 16.32%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$31.4 - $39.07 $607,621 - $756,043
-19,351 Reduced 3.07%
611,731 $23.6 Million
Q2 2024

Oct 17, 2024

SELL
$31.36 - $39.99 $6.46 Million - $8.23 Million
-205,862 Reduced 24.6%
631,082 $20.3 Million
Q2 2024

Aug 14, 2024

SELL
$31.36 - $39.99 $6.46 Million - $8.23 Million
-205,862 Reduced 24.6%
631,082 $20.3 Million
Q1 2024

Oct 17, 2024

BUY
$31.23 - $40.91 $6.43 Million - $8.42 Million
205,862 Added 32.62%
836,944 $32.5 Million
Q1 2024

Aug 16, 2024

SELL
$31.23 - $40.91 $5.15 Million - $6.74 Million
-164,807 Reduced 16.45%
836,944 $32.5 Million
Q1 2024

May 15, 2024

SELL
$31.23 - $40.91 $5.15 Million - $6.74 Million
-164,807 Reduced 16.45%
836,944 $32.5 Million
Q4 2023

Aug 16, 2024

BUY
$21.16 - $30.8 $7.84 Million - $11.4 Million
370,669 Added 58.74%
1,001,751 $30.8 Million
Q4 2023

Feb 13, 2024

BUY
$21.16 - $30.8 $8.75 Million - $12.7 Million
413,286 Added 70.23%
1,001,751 $30.8 Million
Q3 2023

Nov 15, 2023

BUY
$21.23 - $24.28 $847,544 - $969,306
39,922 Added 7.28%
588,465 $13.2 Million
Q2 2023

Aug 14, 2023

SELL
$21.06 - $24.0 $1.47 Million - $1.68 Million
-69,814 Reduced 11.29%
548,543 $11.8 Million
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $5.74 Million - $7.45 Million
249,484 Added 67.63%
618,357 $14.8 Million
Q4 2022

Feb 14, 2023

SELL
$16.14 - $23.55 $745,151 - $1.09 Million
-46,168 Reduced 11.12%
368,873 $8.56 Million
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $594,916 - $773,468
38,481 Added 10.22%
415,041 $6.65 Million
Q2 2022

Oct 27, 2022

BUY
$14.22 - $20.88 $159,690 - $234,482
11,230 Added 3.07%
376,560 $6.67 Million
Q2 2022

Aug 15, 2022

BUY
$14.22 - $20.88 $159,690 - $234,482
11,230 Added 3.07%
376,560 $6.67 Million
Q1 2022

Oct 27, 2022

SELL
$17.2 - $22.5 $193,156 - $252,675
-11,230 Reduced 2.98%
365,330 $7.44 Million
Q1 2022

May 13, 2022

BUY
$17.2 - $22.5 $2.95 Million - $3.86 Million
171,706 Added 88.68%
365,330 $7.44 Million
Q4 2021

Feb 14, 2022

BUY
$17.5 - $21.35 $424,777 - $518,228
24,273 Added 14.33%
193,624 $3.62 Million
Q3 2021

Nov 15, 2021

BUY
$17.75 - $25.39 $3.01 Million - $4.3 Million
169,351 New
169,351 $3.34 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.05B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.